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Abstract
Background: Chronic musculoskeletal pain (CMP) is the most common self-reported chronic pain condition. Current
treatment for CMP is limited.
Methods: This was a two-phase study. In Phase 1, three auricular point acupressure (APA)-naı̈ve participants were recruited
to explore their experiences of APA and a smartphone app was developed based on their feedback. In Phase 2, a prospective
longitudinal study was used to examine the effectiveness of the smartphone app to self-manage CMP.
Results: Phase 1 resulted in the successful development of the APA smartphone app. In Phase 2, after four weeks of APA,
participants reported reduced pain intensity (30%), pain interference (35%), and disability (40%), as well as improved physical
function (47%). The mean score for the participants’ perception of treatment efficacy was 4.94 (SD ¼ 2.08, scale of 0–7)
indicating that approximately 70% of participants rated global improvements with noticeable changes. The majority (88%,
n ¼ 22) of the participants were satisfied with the treatment: 32% [8] were very satisfied and 56% [n ¼ 14] were somewhat
satisfied. The average frequency of pressing APA seeds per day was 2.93 times (SD ¼ 2.27, range 0–10) and 1.60 minutes per
time (SD ¼ 2.64, range 0–10); the participants were able to adhere to the suggested pressing time per day, although they only
pressed the ear points about 53% of the suggested time.
Conclusion: It is feasible for individuals to learn APA from the smartphone app and successfully self-administer APA to
manage their pain. Participants found the app useful and were satisfied with the information provided through the app.
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auricular point acupressure, musculoskeletal pain, smartphone application, self-management
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Background
Chronic musculoskeletal pain (CMP) is the most
common self-reported and clinically diagnosed chronic
pain condition in the U.S.1–6 In 2016, 20% of American
adults reported chronic pain, with 8% suffering from
limitations in their activities of daily living.1 Chronic
pain is the second most common reason for healthcare
provider visits in the U.S.,5,7 with annual expenses over
$635 billion, accounting for medical care costs, reduced
disability-related productivity, and lost wages.8 CMP is
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described as the most common type of chronic pain
occurring frequently in the joints and back,9 lasting
beyond normal healing (3–6 months).8
Pharmacotherapy is currently the predominant treatment for chronic pain in U.S. medical practice;10–14 however, many analgesics are associated with numerous,
potentially deleterious side effects (e.g., nonsteroidal antiinflammatory drugs and their predilection for causing renal
insufficiency, gastrointestinal bleeding, hypertension, congestive heart failure.)15–18 Opioids are also often prescribed
due in part to the convenience of this approach (easy to
prescribe), resulting in an abundance of opioid prescriptions dispensed in the U.S.19 Opioid analgesics are commonly overprescribed and are associated with risks of
addiction, sleep-disordered breathing, delirium, and falls/
fractures,18,20 leading to the current opioid crisis.21
Non-pharmacological therapy and self-management
are recommended in evidence-based guidelines for the
treatment of CMP9,22 but these have barriers for implementation. Self-management alone may be insufficient
for effective, sustained pain management23 and needs to
be supported with other treatment modalities for best
results.24,25 Exercise during randomized clinical trials
(RCTs)22,26 has been shown to be moderately effective
for chronic pain, but long-term adherence after the trials
end is challenging.27 It has been demonstrated that even a
simple physical intervention such as a walking program
has waning efficacy over time.28 Multidisciplinary rehabilitation programs are time-consuming, costly, and labor
intensive, as with physical therapy; to achieve optimal outcomes, patients must carry forward the principles and
practices taught in these programs.29 Further, other suggested treatments such as mindfulness-based stress reduction,30–32 tai chi,33,34 yoga,35,36 cognitive behavioral
therapy,32,37 and spinal manipulation38 have barriers to
scale-up, including patient and provider buy-in, insurance
coverages, and accessibility to care, limiting adherence to
these evidence-based guidelines.20,39–45 Even Acupuncture,
which has supporting evidence to manage pain effectively,9
is hard to scale up because it involves complex assessments
and individualized treatments by trained providers, representing barriers to widespread implementation. Although
these various evidence-based modalities are recommended
in guidelines, challenges continue to exist as to how to best
implement these in practice to enhance utilization.9
Auricular point acupuncture/acupressure (APA) is a
method derived from Traditional Chinese Medicine
(TCM). In the 1950’s, Dr. Paul Nogier, a well-known
French Neurosurgeon, theorized that the ear represents
an inverted fetus within the womb as a somatotopic map
representing reflex parts of the human body.46,47 In
other words, the ear is a microsystem based on reflexology; acupoints for the entire body are represented on the
inner and outer ear lobes.48,49 By stimulating specific
auricular points, corresponding parts of the body that
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are symptomatic can be treated by a stimulus pressed on
the ear acupoints.48,49 The stimulation of the auricular
point can be performed by acupuncture needles, pellets/
seeds, or electric stimulation.48,50
Acupuncture, a well-known treatment in TCM, is
performed by inserting sterile needles into specific
acupoints; it is considered safe when performed by
experienced practitioners.48,49 However, the widespread
application of acupuncture to manage pain is limited by
the paucity of trained acupuncturists, inadequate or lack
of insurance coverage, need for patients to travel frequently to the acupuncture clinic,51 fear of pain caused
by needle insertion,52 and the potential for infection.51
On the other hand, APA is a non-invasive procedure
where acupuncture-like stimulations are done to ear
points using small pellets or seeds instead of needles.
We have plenty of supporting evidence on the efficacy
of APA to self-manage pain.53–65 Comparing APA to
sham (placebo) APA, our studies demonstrated: (1)
rapid and sustained significant effect: APA resulted in
38% rapid pain relief among participants at three
minutes post-APA;66,67 >44% pain relief and >28%
improved physical function at follow-up after a 4-week
APA treatment;53–59 (2) reduction of medication use:
After 4 weeks of APA, 60% of participants reported
less use of pain medications54,63; and (3) significant
impact on physiological measures: APA controls pain
through blocking pro-inflammatory cytokines (IL-1b,
IL-2)60–62 and modulating nerve sensitivity.62 No
adverse effects from APA have been reported.68,69
Despite the long use of traditional Chinese Medicine in
Asia and Europe, APA is relatively new in the U.S. and has
not been widely used, made available, or researched as
extensively as other pain treatments. From our multiple
studies,53–65 we received an overwhelming number of
requests from former study participants for further APA
treatment, and they expressed their desire to incorporate
APA into their pain self-management plans. Therefore, the
purpose of this study was to develop a smartphone application (app) to help increase the use of and access to APA
and then evaluate the feasibility and preliminary efficacy of
this APA smartphone app. We are guided by Lorig’s conceptualization of self-management, grounded in Bandura’s
theory of self-efficacy70 and the National Institute of
Nursing Research (NINR) at the National Institutes
of Health (NIH)71 where patients are able take control of
their care as active participants.72 The key 2011 Institute
of Medicine report on pain emphasized that the majority
of pain care needs to occur through self-management.8

Methods
This study was conducted in two phases. In Phase 1
(developmental phase), three APA naı̈ve participants
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were recruited to explore their experiences in selfadministering APA. Taking their input into account,
the APA smartphone app was developed to act as a
self-guided tool to self-administer APA to manage
pain. In Phase 2, thirty participants were enrolled to
complete a baseline visit (first time point or T1) where
they answered a set of questionnaires. The APA smartphone app was installed into their phones and they
received instructions on how to use the app to administer
APA for 4 weeks. Immediately after the four-week intervention period (second time point or T2), participants
returned for a post-intervention visit to complete the
same questionnaires as in the baseline visit and a qualitative interview about their experiences with APA and
the smartphone app. Participants then completed a
follow-up over the phone after 1-month of completion
of the intervention (third time point or T3).

Design
Phase 1. A purposive sample (APA naı̈ve participants)
was used to select three adult participants (one male
and two females, mean age ¼ 62 years) with CMP who
were enrolled into this study. They received the first
APA treatment provided by a research team member
with background and expertise in APA and instructions
were given on how to self-administer APA at home
(including identifying ear points, placing the seed/tapes
on the ear, and stimulating the ear points). An APA kit
was provided (contains probe, seeds/tapes, and forceps).
After four weeks of self-administered APA, participants
were interviewed to share their experiences with the
research team on practicing APA and barriers to selfadministration.
APA Treatment Protocol. Detailed information about the
APA treatment protocol has been described in our previous publications.53,58,73–75 The ear points to treat pain
include: corresponding ear points (specific ear points
corresponding to participant’s body pain locations on
both sides of the ears, front and back), and Shenmen
and Subcortex points known for alleviating stress and
pain. The protocol included how to locate ear points
corresponding to the body part in pain, how to tape
the seeds on the identified ear points, and how to press
the ear points to achieve pain relief.76,77 Participants
were instructed to evenly press the tapes and seeds covering each ear point without rubbing (to avoid skin
damage or movement of the seed from the ear point)
for three minutes, three times daily (nine minutes
total), even if they were not experiencing pain. The optimal pressure was considered to have been achieved when
the participant felt localized tingling or mild discomfort.
The overall treatment duration was four weekly cycles.
Each weekly cycle included five days of wearing the
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taped seeds and two days without seeds. Participants
were instructed to remove the tape/seeds at the end of
the 5th day, let the ear points rest for two days, and reapply after 2 days. This cycle minimized the risk of allergic reactions to the tape and allowed the ear points to
recover and restore sensitivity prior to the next treatment. After four weeks of APA treatment, they were
interviewed about their experiences about the APA
treatment.
Development of the APA Smartphone App. All three participants reacted extremely positively from the rapid pain
relief they received after stimulating their ear points and
found it was not difficult to self-administer APA based
on their in-person training and instructions provided.
One participant was able to walk and flex their back
much better after about 5 minutes of the treatment.
One participant did mention that it took her several
times to find the right ear points for treatment. Based
on participant feedback from the APA experiences,
videos of the APA protocol were developed. The
videos were reviewed by the three participants and
edited for clarity. It took two editing sessions to finalize
the videos. Figure 1 demonstrates the APA treatment
protocol video for low back pain. The final videos
included:
A. Instructional Video (5 min Long). The instructional video
included: (1) the theoretical background of APA, (2) a
breakdown of the APA kit, and (3) a brief introduction
about the APA treatment protocol.
B. Demonstration Video (3 min Long). The demonstration
video included: (1) how to use the probe to find the
corresponding ear points based on the body area of
pain, (2) how to tape the seeds on the identified ear
points, and (3) how to stimulate the ear points.
The app was made available at the app store
(Android or iOS) after the participants enrolled in the
study. Once downloaded, individuals could access the
videos as many time as they liked.
Phase 2. To examine the feasibility and assess the
preliminary efficacy of the APA smartphone app as a
self-guided tool to self-administer APA, a prospective,
longitudinal study (single group, open trial design) was
conducted. After baseline data were collected (T1),
participants installed the phone app and received
instructions on how to use the app to administer APA
for 4 weeks and self-manage their pain. After the fourweek intervention period, participants returned for an
immediate post-intervention visit (T2), and then completed a 1-month follow-up post-intervention (T3) over
the phone. STRICA guidelines were used in reporting
our findings based on the study design.78
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Figure 1. Auricular Point Acupressure Smartphone App for Musculoskeletal Pain.

Participants and Study Setting
Inclusion criteria: Participants were eligible if they: (1)
were 18 years or older, (2) were able to read and write
English, (3) had CMP for at least 3 months, (4) reported
an average intensity of pain  4 on an 11-point numerical pain scale for the previous week, (5) were smartphone
users, and (6) were able to apply pressure to the seeds
taped on their ears. Participants were excluded if they
had any allergy to latex (tapes used on ear points). This
study was conducted at the Johns Hopkins Medicine
(JHM) Study Office.

Study Instruments
Brief Pain Inventory (BPI)79. The subscale of BPI on “pain
severity/intensity” in the last 7 days was used. The subscale has 4 items assessing pain at its “worst,” “least,”
“average,” and “now (current),” with range of scores
from 0 (“no pain”) to 10 (“pain as bad as you can imagine”). Higher scores indicate that patients have more
severe pain. The BPI also includes pain medication
use, percentage of perceived pain relief by pain medication, and front and back body diagrams for participants
to mark their pain locations. BPI has established reliability and validity cited in over 400 publications.79 To evaluate the magnitude of change in pain intensity, pain
relief was defined as a reduction of 30% in pain intensity. This is considered to be a “moderate clinically important difference” by the Initiative on Methods,
Measurement, and Pain Assessment in Clinical Trials
(IMMPACT)80 and was used to define a significant
effect of APA.33

Roland-Morris Disability Questionnaire (RMDQ)81. This
24-item measure was used to assess the impact of CMP
on daily functioning. Participants were asked to rate yes
or no on the statement related to their physical function.
The scores ranged from 0 (no disability) to 24 (maximum
disability). RMDQ is a reliable, valid, and sensitive measure, demonstrating substantial construct validity.81,82
Pain Catastrophizing Scale (PCS)83. This 13-item, self-report
measure was used to evaluate exaggerated and negative
interpretations of pain. Participants were asked to reflect
on past painful experiences and to indicate to which
degree they experienced each of the following when feeling pain: rumination (4 items), magnification (3 items),
or helplessness (6 items). The PCS features a 0–4 Likert
scale (scores ranged from 0 to 52) from “not at all” to
“all the time.” A higher PCS score indicated stronger
pain catastrophizing.
Fear-Avoidance Beliefs Questionnaire (FABQ)84. A valid and
reliable, modified form of the FABQ84 was used that
focuses on patients’ beliefs about how physical activity
affected their pain (4 items).The FABQ features a 0–6
Likert type scale from 0 (completely disagree) to 6
(completely agree), with scores ranging from 0 to 24.
Higher scores indicated elevated fear-avoidance.
PROMIS 2985. The subscales of “Physical Function”
(4-item), “Anxiety” (4-item), “Depression” (4-item),
and “Fatigue” (4-item) in the PROMIS 29 were used.
The scores for each subscale ranged from 4 to 20, with
higher scores indicating greater symptoms. PROMIS-29
has established reliability and validity86,87 and is widely
used in the U.S.
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Patient Global Impression of Change (PGIC)88. The PGIC was
used to measure the impression of change after completion of this 2-phase study. The PGIC scores reflected a
patient’s belief about the efficacy of a treatment. PGIC is
a 7-point scale depicting a patient’s rating of overall
improvement ranging from “very much improved” (1)
to “very much worse” (7). PGIC has established psychometric properties to identify clinically significant changes
in patients’ subjective outcome measures.88
Treatment Satisfaction89. This is a one-item scale and was
used to assess participants’ satisfaction with the treatment. The scores ranged from 1 (“completely satisfied”),
2 (“somewhat satisfied”), to 3 (“not satisfied”). This satisfaction survey has been used effectively in our previous
study on low back pain with APA.89
APA Practice89. This is measured using a two-item, openended scale to collect how participants practiced their
APA. The scale asks “How many times did you press
the seed per day” and “How long did you press the seeds
each time.” APA adherence to practice was defined by
the number of participants who were able to follow at
least two-thirds of the suggested pressing time (at least
two times/day, two minutes/time).55,89,90 This measure
was used succesfully in our previous study on low back
pain.55,89,90
Demographic and Health History Data. A questionnaire was
used to collect demographic information (e.g., age, marital status, educational level, employment, estimated
income), pain location, and pain medications used.

Procedure
We promoted the study information and recruited participants by using online study flyers distributed at outpatient clinics at JHM Johns Hopkins Pain Treatment
Center, referrals from physicians, and social media
advertisement websites (e.g., Craigslist, Inc.). This
study was approved by the Insitutional Review Board
(IRB) at JHM. After consents were obtained and baseline data were collected, participants installed the APA
smartphone app on their phones and received the APA
kit. They then self-administered APA for four weeks to
manage their pain using the APA smartphone app as a
self-management guide or tool to practice APA. Study
outcomes were assessed at baseline (T1), immediately
post-intervention (T2), and at the 1-month follow-up
after the intervention (T3). Data were collected using
the Research Electronic Data Capture (REDCap),
which is a secure data management system approved
by the IRB as compliant with HIPAA security policies.
A brief interview was conducted at T2 to explore participants’ experiences about the app. The interviews were
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recorded so that transcripts could be reviewed for
analysis.

Data Analyses
Based on the nature of this study (small sample size),
descriptive analyses (means and standard deviations)
were used to examine the outcome measures. Data analyses were based on the participants who completed all of
the data assessments (n ¼ 25, 83%). Effect size as standardized differences in mean between two means
(Cohen’s d) was calculated; this would inform the
sample sizes for future randomized controlled trials.
All data analyses were performed using SPSS 25!. For
the interview data, transcripts of audio-recordings were
analyzed using conventional content analysis.91
Common suggestions and concerns were extracted to
address issues with the feasibility of the APA smartphone app.

Results
Feasibility of Recruitment
For recruitment, we received 31 referrals from healthcare providers and 55 inquiries from individuals who
learned of our study from our advertisements. Fifty-six
participants were excluded for various reasons
(Figure 2). Of the 30 remaining who were enrolled in
this study, two dropped out because of new medical
conditions unrelated to APA; one dropped out because
of a very busy schedule, and two failed to schedule their
post-intervention visit. Consequently, 25 participants
completed this study (83% retention rate).

Participants’ Characteristics
Table 1 presents the demographic characteristics of 30
participants. The average age of the participants was
54 years (SD ¼ 12.49, ranging from 22 to 68). Among
the 30 participants, the majority were women (n ¼ 25,
83%), Whites (n ¼ 15, 50%), and had college degrees
or more (n ¼ 23, 77%). The average multisite body
pain locations were 2.9 (SD ¼ 1.18, range 1–5). These
pain locations frequently included the back (83%),
neck (73%), knee (47%), finger (40%), and foot
(40%). Approximately 43% of the participants took
medications to treat their pain.

Feasibility of APA Practice
The results indicated that the average frequency of pressing the seeds per day among the participants was 2.96
times (SD ¼ 2.27, range 0–10), at 1.6 minutes per time
(SD ¼ 2.64, range 0–10). Two participants indicated
their ear was sore after pressing and one participant
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Figure 2. Participant Recruitment Flowchart.

had sensitivity to the tapes used. Among 13 participants
who used pain medications, 77% (n ¼ 10) reported that
they took less pain medications during the intervention
and follow-up phase, and 88% (n ¼ 22) indicated they
will refer APA to their family or friends.

Anxiety, Depression, Sleep Quality, and Fatigue (PROMIS 29).
As shown in Table 2, the changes in these scores using
the PROMIS 29 subscales were modest at both data time
points (T2 and T3) compared to baseline and also in
comparison to the other outcome measures.

APA Treatment Outcomes

Patient’s Global Impression of Change. The mean score for
the participants’ perceptions of treatment efficacy was
4.94 (SD ¼ 2.08, scale of 0-7). This finding indicates
that about 70% of participants rated their global
improvement as “moderately better, and slight but
noticeable changes”).

Pain Intensity, Interference, Disability, and Physical Function.
After 4 weeks of APA treatment, pain intensity
decreased by 35% (T2) at immediate post-APA and
was maintained by 30% at 1-month follow-up (T3) compared to baseline (T1) (Table 2). Cohen’s effect size
(d ¼ 0.96) suggested a high improvement in the decrease
of pain intensity. Pain interference also decreased by
35% at T2 and was closely maintained at 29% at T3
compared to baseline. Cohen’s effect size (d ¼ 0.35) suggested a moderate improvement in decreased pain interference. Based on the score from the RMDQ,
participants had decreased (39%) disability at T2,
which continued to decrease to 40% at the 1-month
follow-up (T3). Cohen’s effect size (d ¼ 0.69) suggested
a moderate improvement in reducing disability. The
score from the PROMIS subscale of physical function
showed improved function (14%) at T2, which dramatically improved (47%) at T3. Cohen’s effect size
(d ¼ 1.30) suggested a moderate improvement in physical
function.
Pain Catastrophizing and Fear-Avoidance Beliefs. As shown in
Table 2, participants reported a lower pain catastrophizing score (16%) at T2 and maintained a similar
decreased magnitude (18%) at T3 compared to baseline.
Fear-avoidance beliefs decreased to 27% at T2 and
maintained the same magnitude at T3 compared to
baseline.

Satisfaction From APA. The majority (88%, n ¼ 22) of the
participants were satisfied with the treatment (32% [8]
were very satisfied and 56% [n ¼ 14] were somewhat satisfied). However, 12% (n ¼ 3) of the participants were
not satisfied with the treatment. These 3 participants
stated that they did not feel significant changes in their
pain intensity after the treatment.
Adherence to APA Practice. The average frequency of pressing the seeds per day was 2.93 times (SD ¼ 2.27, range 010) and 1.60 minutes per time (SD ¼ 2.64, range 0-10),
indicating that the participants were able to adhere to
the recommended pressing frequency per day (3 times
per day), but they only pressed the ear points about
53% of suggested pressing time (3 minutes per time).
Side Effects of APA Treatment. Few participants indicated
that the ear points exhibited soreness (n ¼ 1), tenderness
(n ¼ 1), or redness due to tape sensitivity (n ¼ 3). Four
participants complained that the tape fell off easily. No
adverse effects were reported; regardless, these participants continued their APA treatment for pain relief.

Kawi et al.
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Table 1. Characteristics of the Participants (N ¼ 30).
Variable
Age
Mean (SD) (Range)
Gender
Male
Female
Race/ethnicity (n)
White
Black/African American
More than one race
Marital status (n)*
Currently married
Divorced
Widowed
Never married
Separated
Living with a partner
Employment situation (n)*
Working (full time)
Working (part time)
Not employed
Retired
Education level (n)*
High school
Some college
College graduate
Post-graduate degree
Estimated income before taxes (n)*
Less than $10,000
$10,000 to $19,999
$20,000 to $39,999
$40,000 to $59,000
$60,000 to $100,000
More than $100,000
Current pain medication use (n)
Yes
No
Current sleep medication use (n)
Yes
No
Number of pain locations
Mean (SD) (Range)
Back
Neck
Knee
Finger
Shoulder
Foot
Hip
Leg

N (%)
54.0 (12.49) (22–68)
5 (17)
25 (83)
15 (50)
12 (40)
3 (1)
9
4
4
10
1
2

(30)
(13)
(13)
(34)
(3)
(7)

13
4
11
2

(43)
(13)
(37)
(7)

2
5
9
14

(7)
(16)
(30)
(47)

3
8
5
4
7
3

(10)
(27)
(17)
(13)
(23)
(10)

13 (43)
17 (57)
3 (10)
27 (90)
2.9
25
22
14
12
6
12
6
4

(1.18) (1–5)
(83)
(73)
(47)
(40)
(20)
(40)
(20)
(13)

*n varies due to missing data.

Qualitative Data Findings. Participants appreciated the
instructional videos that provided background information about the concept of APA and the pain relief
achieved when following the treatment protocol.

The majority of the participants (80%, n ¼ 20) expressed
that they were able to learn how to self-administer APA
using the smartphone app. However, five participants
conveyed a need to re-watch the videos multiple times
to accurately identify ear point locations. Furthermore,
they were not aware of the need to use the probe to
locate tender points on the ear and subsequently use
those tender points as areas for seed placement. Five
patients favored the possibility of doing an in-person
training. Three participants indicated that the seeds/
tapes did not stay on the ear well and that they possibly
had sensitivity to the latex tape used. Four participants
indicated that the training could be improved if they
were able to review the videos on a computer or tablet
since the screen on their smartphone was too small.

Discussion
APA is a relatively safe treatment to manage pain and
can be used as an option to manage CMP. Minor concerns from the study participants were soreness or tenderness on their ears when self-administering the APA
treatment, redness from the tapes used to secure the
seeds, or tapes easily falling off. However, these participants stated that the soreness was bearable compared to
their body pain and that the treatment was worth pursuing to achieve pain relief. To improve APA practice,
hypoallergenic and latex-free tape and ear seeds can be
used. Another option could be the development of a
finger cot which only covers the finger with embedded
pellets on the fingertip so that participants can stimulate
the ear points anywhere and anytime as needed without
using tape. Unlike body acupressure—which usually
requires different degrees of pressure on body points
for about 30–40 minutes per session and usually requires
a therapist, especially when body acupoints are not
accessible to the patients themselves—auricular points
are at a superficial skin level, within easy reach, and
take less time to implement. Patients simply press the
seeds for 3 minutes, three times per day (i.e., 9 minutes
total per day) to relieve pain. This is time-efficient, combines active participation with potential for immediate
pain relief, and provides patients with a greater sense of
control over their pain, thereby allowing them to resume
daily tasks that CMP prevented them from performing.
Our APA smartphone app protocol includes teaching
patients regarding the treatment rationale (i.e., mechanisms by which APA can alleviate CMP), skill training
(i.e., learning how to identify the ear points and press the
seeds), and maintenance of learned skills (adherence to
the treatment regimen) to help facilitate sustainability of
the APA practice.
This is the first study to develop an APA smartphone
app as a self-guided tool to self-administer APA for
participants with CMP and to examine the feasibility
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Table 2. Smartphone Auricular Point Acupressure App Outcomes (n ¼ 25).
Change
Change
Pre-Intervention Post-Intervention (Post-Pre) Cohen’s d 1M Follow-Up (1 M-Pre) Cohen’s d
Mean (SD)
Mean (SD)
%
(effect size)
Mean (SD)
%
(effect size)
Pain Intensity
Pain Interference
Physical Function
Function (PROMIS-29)
Function (RMDQ)
Psychological function
PCS
Fear
Depression (PROMIS-29)
Anxiety (PROMIS-29)
Other function
Sleep (PROMIS-29)
Fatigue (PROMIS-29)

7.2 (1.80)
19.9 (18.74)

4.7 (2.86)
13.0 (13.29)

35%
35%

1.06
0.42

5.0 (2.67)
14.2 (13.46)

30%
29%

0.96
0.35

11.3 (5.23)
9.1 (6.12)

9.6 (3.61)
5.5 (5.06)

14%
39%

0.36
0.63

6.0 (2.32)
5.4 (4.25)

47%
40%

1.30
0.69

16%
27%
4%
6%

0.19
0.36
0.08
0.13

10.2
10.3
5.6
7.2

18%
27%
16%
4%

0.22
0.35
0.34
0.07

4%
8%

0.20
0.17

10.6 (1.86)
10.5 (4.98)

7%
13%

0.35
0.29

12.4
14.2
6.7
7.5

(10.43)
(12.00)
(3.47)
(3.88)

11.4 (2.53)
12.1 (5.89)

10.4
10.3
6.5
7.0

(9.91)
(9.59))
(3.17)
(2.90)

10.9 (2.55)
11.2 (5.33)

(9.45)
(9.89))
(2.62)
(3.30)

RMDQ¼ Roland-Morris Disability Questionnaire, PCS¼Pain Catastrophizing scale, Effect size uses change to either post-intervention or 1 M-follow-up
from pre-intervention as an estimate of change in control condition.

and initial treatment efficacy of a 4-week APA protocol
to manage CMP. Our smartphone app was found to be
user friendly. Participants found it easy to follow and
were able to use it to guide their APA practice. This
app empowers participants to self-manage their pain.
Our study findings indicate that it is feasible for participants to learn APA from the smartphone app and successfully self-administer APA to manage their pain, with
sustained effects at 1-month follow-up. We reported the
effect sizes of the study outcomes to inform sample size
estimation for a future trial, although the interpretation
needs to be taken with caution due to the following: (1)
small sample size given the nature of the pilot study; (2)
heterogeneity of pain conditions in CMP limit generalizability of study findings; (3) lack of a placebo-control
group and randomization, so we were not able to differentiate the true effects of APA; (3) given that only 1month follow-up data were collected, we were not able
to assess the longer effects of APA on CMP; and (4) we
excluded participants who did not have a smartphone.
Future studies should include a larger sample size,
robust study design (i.e., randomized controlled trials,
comparative effectiveness trials), and a longer followup phase. Future directions in research should also
include evaluating this app as part of a remotely delivered pain program for easy accessibility as well as for
assessing its application among underserved and other
pain populations.
While the APA smartphone app developed in this
study showed preliminary efficacy to manage CMP,
challenges remain that need to be addressed in order
to maximize the usability and accessibility of APA.
First, some participants preferred to watch the videos
through a computer or tablet with bigger screens

compared to smaller screens on smartphones. We suggest modifying the smartphone app to become compatible with web-based interfaces on computers or tablets.
Secondly, the APA treatment protocol, which
includes auricular points corresponding to painful
body parts, and the procedure for identifying auricular
points are new concepts and techniques for the study
participants and required multiple views of the videos
to learn APA. The smartphone app videos developed
in the current study included two sets of videos: one
instructional video (approximately 5 minutes long) and
one demonstration video (approximately 3 minutes). If
the participants wanted to review a specific segment of
the video, they needed to rewind the video many times to
locate the exact video segment they needed. To facilitate
learning outcomes, the “microlearning” technique can be
used by breaking learning content into shorter videos,
adding quality graphics, and incorporating visual aids to
assist with participant retention of the knowledge they
learn.92 We suggest that each piece of content be divided
into approximately one-minute videos to facilitate easier
learning and understanding. Microlearning can be selfpaced, repeated, and re-emphasized based on the participants’ learning progress. Each video can be followed by
a knowledge test to ensure APA retention before
advancing to the next video. Additionally, the videos
should accommodate closed captioning and have larger
font sizes for the visually impaired.
Last, to facilitate self-monitoring and to motivate
participant’s adherence to APA practice and effectively
self-manage pain, we suggest that the APA smartphone
app include an individualized dashboard with userfriendly visual summaries of study outcomes and
APA practice. Another recommendation is to include

Kawi et al.
pre-programmed motivational messages according to
daily scores of pain outcomes to encourage APA practice based on tried quotes and postings given to patients
with chronic disorders such as pain.93–95
We conclude that the APA smartphone app is an
ideal tool for training individuals to self-administer
APA. Up to 81% of Americans own a smartphone96
and online technology remains an effective tool to facilitate knowledge translation from research findings to
end-users.24,97,98 In this study, we found that the participants were able to learn APA from the app and subsequently foster APA into a self-management plan to
reduce their pain. APA is a non-invasive treatment and
can be easily administered and used as an adjunct treatment to self-manage CMP, allowing patients to resume
many daily tasks interrupted by their pain. More importantly, once learned, patients can incorporate APA into
a self-management plan that best fits their specific needs
given the nuances in various pain conditions to habitually manage their pain when present, especially since
CMP oftentimes comes and goes. The availability of
APA as an adjunct to standard care offers the potential
to improve patients’ quality of life in a cost-effective
manner. We believe that replicating this study in a randomized clinical trial with a larger sample size and a
control group is the next step to confirm the efficacy
of APA for treating CMP.
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